- $137.21m
- -$52.17m
- 10
- 39
- 18
- 11
Annual balance sheet for Invivyd, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 115 | 591 | 372 | 201 |
| Net Total Receivables | — | — | 0.377 | 0.933 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 117 | 617 | 377 | 225 |
| Net Property, Plant And Equipment | — | 0.083 | 6.06 | 4.13 |
| Other Long Term Assets | ||||
| Total Assets | 117 | 620 | 383 | 229 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 13.1 | 62.1 | 25 | 50.3 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 13.1 | 62.1 | 27.2 | 51.7 |
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| Other Equity | ||||
| Total Equity | 104 | 558 | 356 | 177 |
| Total Liabilities & Shareholders' Equity | 117 | 620 | 383 | 229 |
| Total Common Shares Outstanding |